|
1
|
Ferlay J, Soerjomataram II, Dikshit R, et
al: Cancer incidence and mortality worldwide: sources, methods and
major patterns in GLOBOCAN 2012. Int J Cancer. Sep 13–2014.(Epub
ahead of print). PubMed/NCBI
|
|
2
|
Bozzuto G, Ruggieri P and Molinari A:
Molecular aspects of tumor cell migration and invasion. Ann Ist
Super Sanita. 46:66–80. 2010.PubMed/NCBI
|
|
3
|
Ballinger CA, Connell P, Wu Y, et al:
Identification of CHIP, a novel tetratricopeptide repeat-containing
protein that interacts with heat shock proteins and negatively
regulates chaperone functions. Mol Cell Biol. 19:4535–4545.
1999.PubMed/NCBI
|
|
4
|
McDonough H and Patterson C: CHIP: a link
between the chaperone and proteasome systems. Cell Stress
Chaperones. 8:303–308. 2003. View Article : Google Scholar
|
|
5
|
Connell P, Ballinger CA, Jiang J, et al:
The co-chaperone CHIP regulates protein triage decisions mediated
by heat-shock proteins. Nat Cell Biol. 3:93–96. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meacham GC, Patterson C, Zhang W, Younger
JM and Cyr DM: The Hsc70 co-chaperone CHIP targets immature CFTR
for proteasomal degradation. Nat Cell Biol. 3:100–105. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Urushitani M, Kurisu J, Tateno M, et al:
CHIP promotes proteasomal degradation of familial ALS-linked mutant
SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem. 90:231–244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patani N, Jiang W, Newbold R and Mokbel K:
Prognostic implications of carboxyl-terminus of Hsc70 interacting
protein and lysyl-oxidase expression in human breast cancer. J
Carcinog. 9:92010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun C, Li HL, Shi ML, Liu QH, Bai J and
Zheng JN: Diverse roles of C-terminal Hsp70-interacting protein
(CHIP) in tumorigenesis. J Cancer Res Clin Oncol. 140:189–197.
2014. View Article : Google Scholar
|
|
10
|
Wang Y, Ren F, Feng Y, et al: CHIP/Stub1
functions as a tumor suppressor and represses NF-kappaB-mediated
signaling in colorectal cancer. Carcinogenesis. 35:983–991. 2014.
View Article : Google Scholar
|
|
11
|
Kajiro M, Hirota R, Nakajima Y, et al: The
ubiquitin ligase CHIP acts as an upstream regulator of oncogenic
pathways. Nat Cell Biol. 11:312–319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jang KW, Lee KH, Kim SH, et al: Ubiquitin
ligase CHIP induces TRAF2 proteasomal degradation and NF-kappaB
inactivation to regulate breast cancer cell invasion. J Cell
Biochem. 112:3612–3620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang S, Wu X, Zhang J, et al: CHIP
functions as a novel suppressor of tumour angiogenesis with
prognostic significance in human gastric cancer. Gut. 62:496–508.
2013. View Article : Google Scholar
|
|
14
|
Xu J, Zhou P, Wang W, Sun A and Guo F:
RelB, together with RelA, sustains cell survival and confers
proteasome inhibitor sensitivity of chronic lymphocytic leukemia
cells from bone marrow. J Mol Med (Berl). 92:77–92. 2014.
View Article : Google Scholar
|
|
15
|
Vallabhapurap US and Karin M: Regulation
and function of NF-kappaB transcription factors in the immune
system. Annu Rev Immunol. 27:693–733. 2009. View Article : Google Scholar
|
|
16
|
Shih VF, Tsui R, Caldwell A and Hoffmann
A: A single NFkappaB system for both canonical and non-canonical
signaling. Cell Res. 21:86–102. 2011. View Article : Google Scholar
|
|
17
|
Sun SC: Non-canonical NF-kappaB signaling
pathway. Cell Res. 21:71–85. 2011. View Article : Google Scholar
|
|
18
|
Shu HB, Takeuchi M and Goeddel DV: The
tumor necrosis factor receptor 2 signal transducers TRAF2 and
c-IAP1 are components of the tumor necrosis factor receptor 1
signaling complex. Proc Natl Acad Sci USA. 93:13973–13978. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karl I, Jossberger-Werner M, Schmidt N, et
al: TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and
necroptosis. Cell Death Dis. 5:e14442014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hayden MS and Ghosh S: NF-kappaB, the
first quarter-century: remarkable progress and outstanding
questions. Genes Dev. 26:203–234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Holley AK, Xu Y, St Clair DK and St Clair
WH: RelB regulates manganese superoxide dismutase gene and
resistance to ionizing radiation of prostate cancer cells. Ann NY
Acad Sci. 1201:129–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Belguise K, O’Neill CF, et al:
RelB NF-kappaB represses estrogen receptor alpha expression via
induction of the zinc finger protein Blimp1. Mol Cell Biol.
29:3832–3844. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lukaszewicz-Zajac M, Mroczko B and
Szmitkowski M: Gastric cancer - the role of matrix
metalloproteinases in tumor progression. Clin Chim Acta.
412:1725–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galis ZS, Muszynski M, Sukhova GK, et al:
Cytokine-stimulated human vascular smooth muscle cells synthesize a
complement of enzymes required for extracellular matrix digestion.
Circ Res. 75:181–189. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chu D, Zhang Z, Li Y, et al: Matrix
metalloproteinase-9 is associated with disease-free survival and
overall survival in patients with gastric cancer. Int J Cancer.
129:887–895. 2011. View Article : Google Scholar
|
|
26
|
Zhang M, Zhu GY, Gao HY, Zhao SP and Xue
Y: Expression of tissue levels of matrix metalloproteinases and
tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
J Surg Oncol. 103:243–247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alakus H, Grass G, Hennecken JK, et al:
Clinicopathological significance of MMP-2 and its specific
inhibitor TIMP-2 in gastric cancer. Histol Histopathol. 23:917–923.
2008.PubMed/NCBI
|
|
28
|
Gao ZL, Zhang C, Du GY and Lu ZJ: Clinical
significance of changes in tumor markers, extracellular matrix,
MMP-9 and VEGF in patients with gastric carcinoma.
Hepatogastroenterology. 54:1591–1595. 2007.PubMed/NCBI
|
|
29
|
Zhou Y, Li G, Wu J, et al:
Clinicopathological significance of E-cadherin, VEGF, and MMPs in
gastric cancer. Tumour Biol. 31:549–558. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eberhardt W, Huwiler A, Beck KF, Walpen S
and Pfeilschifter J: Amplification of IL-1 beta-induced matrix
metalloproteinase-9 expression by superoxide in rat glomerular
mesangial cells is mediated by increased activities of NF-kappa B
and activating protein-1 and involves activation of the
mitogen-activated protein kinase pathways. J Immunol.
165:5788–5797. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang Q, Lan F, Wang X, et al:
IL-1beta-induced activation of p38 promotes metastasis in gastric
adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol
Cancer. 13:182014. View Article : Google Scholar
|
|
32
|
Han TS, Hur K, Xu G, et al: MicroRNA-29c
mediates initiation of gastric carcinogenesis by directly targeting
ITGB1. Gut. May 28–2014.(Epub ahead of print). pii:
gutjnl-2013306640. PubMed/NCBI
|
|
33
|
Zhao ZS, Li L, Wang HJ and Wang YY:
Expression and prognostic significance of CEACAM6, ITGB1, and CYR61
in peripheral blood of patients with gastric cancer. J Surg Oncol.
104:525–529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu ZY, Chen JS and Shu YQ: Gene expression
profile towards the prediction of patient survival of gastric
cancer. Biomed Pharmacother. 64:133–139. 2010. View Article : Google Scholar
|
|
35
|
Lin MT, Chang CC, Lin BR, et al: Elevated
expression of Cyr61 enhances peritoneal dissemination of gastric
cancer cells through integrin alpha2beta1. J Biol Chem.
282:34594–34604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ura H, Denno R, Hirata K, Yamaguchi K and
Yasoshima T: Separate functions of alpha2beta1 and alpha3beta1
integrins in the metastatic process of human gastric carcinoma.
Surg Today. 28:1001–1006. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ahmed KM, Zhang H and Park CC: NF-kappaB
regulates radioresistance mediated by beta1-integrin in
three-dimensional culture of breast cancer cells. Cancer Res.
73:3737–3748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saito T, Sasaki CY, Rezanka LJ, Ghosh P
and Longo DL: p52-independent nuclear translocation of RelB
promotes LPS-induced attachment. Biochem Biophys Res Commun.
391:235–241. 2010. View Article : Google Scholar :
|
|
39
|
Xu T, Zhou Q, Zhou J, et al: Carboxyl
terminus of Hsp70-interacting protein (CHIP) contributes to human
glioma oncogenesis. Cancer Sci. 102:959–966. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wen J, Luo KJ, Hu Y, Yang H and Fu JH:
Metastatic lymph node CHIP expression is a potential prognostic
marker for resected esophageal squamous cell carcinoma patients.
Ann Surg Oncol. 20:1668–1675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gan L, Liu DB, Lu HF, et al: Decreased
expression of the carboxyl terminus of heat shock cognate 70
interacting protein in human gastric cancer and its clinical
significance. Oncol Rep. 28:1392–1398. 2012.PubMed/NCBI
|
|
42
|
Wang X, Belguise K, Kersual N, et al:
Oestrogen signalling inhibits invasive phenotype by repressing RelB
and its target BCL2. Nat Cell Biol. 9:470–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lv Y, Song S, Zhang K, Gao H and Ma R:
CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells.
PLoS One. 8:e833122013. View Article : Google Scholar :
|
